Delivery Order SPE2DR25D3009-SPE2DR26FWHD1
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,391.80 by the Defense Logistics Agency on July 21, 2025, for the supply of Shingrix vial kits. This firm fixed-price contract represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Shingrix vial kits valued at $10,003.60 by the Defense Logistics Agency on September 3, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and operates under a competitive, non-set-aside procurement. This award is a child contract under AmerisourceBergen's significant Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,355.01 on September 3, 2025, for the supply of Shingrix vial kits. This competitively awarded, firm fixed-price contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,587.57 for Shingrix vial kits by the Defense Logistics Agency (DLA) on January 2, 2026, with a completion deadline of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,357.35 by the Defense Logistics Agency (DLA) for Shingrix vial kits, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal contracting relationship with DLA. This award falls...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,374.50 for Shingrix vial kits under a Firm Fixed Price contract by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with an ultimate completion date of September 22, 2025. The award carries no set-aside designation and represents a competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 2, 2026, for the supply of Shingrix vaccine vial kits with a ceiling value of $4,197.53. The contract is firm fixed price with an ultimate completion date of January 5, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made without a set-aside designation, indicating it was competitively awarded through open competition. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $8,301.01 firm fixed-price delivery order by the Defense Logistics Agency on July 15, 2025, for the supply of Shingrix vial kits. The contract is non-competitive and classified as a child award, indicating it derives from a larger indefinite delivery vehicle. This delivery order will be fulfilled at the contractor's corporate office location in Conshohocken, PA, with an ultimate completion date of July 16,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of Shingrix vial kits, a recombinant zoster vaccine. This non-set-aside, competitively awarded contract has a ceiling value of $1,102.87 with a firm fixed price structure and an ultimate completion date of December 19, 2025. The delivery order is performed at the contractor's Corporate Office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $79,544.85 on July 24, 2025, for the supply of Shingrix vaccine vials (10-dose kits) under a firm fixed-price contract. The award is not set-aside and carries an ultimate completion date of August 20, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHD1Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,596.12 by the Defense Logistics Agency on January 6, 2026, for the supply of Shingrix vial kits. The award is a firm fixed-price contract with an ultimate completion date of January 7, 2026, and represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), the awardee is a critical vendor in the federal pharmaceutical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of Shingrix vial kits—a recombinant zoster vaccine—supports military medical readiness and preventive health initiatives across the Department of Defense healthcare enterprise. The company's extensive portfolio of federal contracts demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $88.6k | 1/5/26 |